Aikang Medical Holdings Limited ("Aikang Medical" or "Company") commercializes and applies 3D printing technology to implants in bone, joint and spinal replacements, and occupies a leading position in the bone and joint implants market in China. Aikang Medical designs, develops, produces and sells orthopedic implants, and specializes in hip and knee replacement implants. Aikang Medical's products include bone and joint implants for primary surgery and bone joint implants specially designed for the replacement, repair or upgrading of implants or components of previous operations. Aikang Medical also sells orthopaedic products produced by third parties as a distributor to complement the product portfolio provided by the company to its customers.
Aikang Medical sells its products under the brand name "Aikang". After years of development, it has become a best-selling brand of intra-articular implants in China. In terms of revenue in 2017, Aikang is also a best-selling brand of intra-articular implants in China.
Aikang Medical developed a personalized 3D precision construction technology solution ("3D ACT solution") in July 2014. 3D ACT solutions help surgeons simulate and plan operations, simplify surgical procedures, provide personalized surgical instruments and selected implants before surgery, and significantly improve patient recovery. Aikang Medical's regular products and 3D printing products are regulated by the Food and Drug Administration. Currently, the company's three 3D printing products include hip replacement implants, spinal interbody fusion cages and artificial vertebrae. Aikang Medical is an one-stop orthopedic surgery solution company that combines all four services, including 3D imaging and 3D modeling, providing 3D printed models and customized surgical plans for patients, producing 3D printed surgical instruments and 3D printed implants for bone and joint replacement.
Aikang Medical has an extensive and growing national distribution network. As of December 31, 2017, Aikang Medical's products have more than 650 distributors, covering all provinces in China and 23 overseas jurisdictions. The company also sells some of its products directly to hospitals through wholly-owned subsidiaries holding the relevant distributor licence. The company mainly maintains these direct sales to establish and maintain direct contacts with some of the company's major terminal hospital customers and surgeons.
CEO： Zhijiang Li
Market： Hong Kong motherboard
Listing Date： 12/20/2017